Neoadjuvant Pembrolizumab for Muscle-invasive Urothelial Bladder Carcinoma
Clinical trial NCT02736266 · COMPLETED
Trial details
- NCT number
- NCT02736266
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-27
- Primary completion
- 2018-10-20
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.